Join The Talk You are not logged in.  |   Login  |   Register  |   View Topics  |   Medical Commentator Bios  |  

Health Headlines

Exercise may delay age-related elevated cholesterol, among men.
Half of heart disease deaths may be due to preventable factors, among US adults ages 45 to 79 years.
Staying calm and collected in a stressful situation lowers the body’s inflammatory processes.
MORE health and medical news delivered to your email every week:
 
Vitamins B2 (riboflavin), B3 (niacin), B6 (pyridoxine), and B12 (cobalamin) may protect against cataract occurrence and development.
Allicin exerts cardiovascular effects via the gut, where the compound prevents metabolism of certain amino acids into trimethylamine N-oxide (TMAO).
Fine particulate air pollution (PM2.5) below US Environmental Protection Agency (EPA) standards linked to higher death rates, among men and women ages 65 and ol
New Zealand blackcurrants may help manage aging-related declines in memory accuracy, attention, and mood.
Rapamycin reduces body fat and appetite, in a lab animal model.
Omega-3 supplements and antioxidants improve clearance of amyloid beta protein and reduce inflammation of brain tissue, in people with early stages of Alzheimer
Poor sleep raises risk of heart attack and stroke.
Anti-Aging Forum

WorldHealth.net

Community


 
 
Withania somnifera Studied for Brain Health and Cognition

Researchers found that Withania somnifera modulates Alzheimer’s disease pathology, according to a study published in February 2012. Withania somnifera (ashwagandha) is a commonly used botanical in Ayurvedic medicine for its rejuvenating and antioxidant properties and modulation of inflammatory pathways, the stress response and immune system activity.

The study used transgenic mice with accelerated Alzheimer’s disease pathology and beta-amyloid plaque deposition, which is implicated in the development of Alzheimer’s disease. The mice received Withania somnifera root extract for 30 days.

Withania somnifera administration resulted in reversal of behavioral deficits, plaque pathology and accumulation of beta-amyloid peptides in the brains of middle-aged and old mice. In addition, after seven days of Withania somnifera administration, beta-amyloid peptides were increased in the plasma and decreased in the brain, indicating increased transport of the peptides from the brain to the periphery.

Also after seven days, there was an increase in low-density lipoprotein receptor-related protein and the beta-amyloid peptide-degrading protease neprilysin in the liver and a rise in plasma soluble low-density lipoprotein receptor-related protein. After 14 to 21 days of declining beta-amyloid peptides in the brain, the researchers found an increase in the expression of low-density lipoprotein receptor-related protein in brain microvessels and neprilysin. The researchers state that this promotes clearance of brain beta-amyloid peptides.

The investigators concluded, "The remarkable therapeutic effect of Withania somnifera mediated through up-regulation of liver low-density lipoprotein receptor-related protein indicates that targeting the periphery offers a unique mechanism for beta-amyloid peptide clearance and reverses the behavioral deficits and pathology seen in Alzheimer's disease models.”

Reference:
Sehgal N, et al. Proc Natl Acad Sci U S A. 2012;9:3510-5.
Together we can Change the Health of the World,
Chris D. Meletis, ND


Rate this topic:
1 2 3 4 5
You have submitted a rating for this topic.
Page: 1

Please login to post a reply.



Worldhealth.net Forum is Powered by Sphene Community Tools
DISCLAIMER: The informational material appearing at The World Health Network Forum (“WHN Forum”) is for educational purposes only and is not intended to prevent, diagnose, treat or cure disease or illness. The posts on The World Health Network Forum are the opinion of the specific author and are not statements of advice, opinion, or factual information implied or expressed by or on behalf of The American Academy of Anti-Aging Medicine (A4M), The World Health Network (WHN), or officers, employees, or contracted agents of the aforementioned entities, none of whom make any claims to promote, endorse, suggest, nor recommend any informational material appearing at The WHN Forum. The American Academy of Anti-Aging Medicine (A4M), The World Health Network (WHN), and officers, employees, and contracted agents of the aforementioned entities do not advocate the use of any particular healthcare protocol or therapeutic agent, but The WHN Forum shares such informational material available with the public. The content of posts at The WHN Forum, including but not limited to links to other web sites, are the expressed opinion of the original author and are in no way representative of or endorsed by The American Academy of Anti-Aging Medicine (A4M), The World Health Network (WHN), and officers, employees, and contracted agents of the aforementioned entities. The WHN Forum is provided "as is" without warranty of any kind, either expressed or implied. You should not assume that The WHN Forum is error-free or that it will be suitable for the particular purpose which you have in mind when using it. In no event shall American Academy of Anti-Aging Medicine (A4M), The World Health Network (WHN), and officers, employees, and contracted agents of the aforementioned entities be liable for any special, incidental, indirect or consequential damages of any kind, or any damages whatsoever, including, without limitation, those resulting from loss of use, data or profits, whether or not advised of the possibility of damage, and on any theory of liability, arising out of or in connection with the use or performance of The WHN Forum or other documents which are referenced by or linked to The WHN Forum.




Platinum ELITE sponsors
GOLD sponsors
SILVER sponsors
Media Partners